Aurora Investment Counsel Makes New Investment in Molina Healthcare, Inc. (NYSE:MOH)

Aurora Investment Counsel bought a new stake in shares of Molina Healthcare, Inc. (NYSE:MOH) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 6,254 shares of the company’s stock, valued at approximately $1,859,000.

Several other institutional investors and hedge funds have also modified their holdings of MOH. Quent Capital LLC raised its stake in shares of Molina Healthcare by 6.8% in the 1st quarter. Quent Capital LLC now owns 489 shares of the company’s stock valued at $201,000 after acquiring an additional 31 shares in the last quarter. Clear Creek Financial Management LLC boosted its holdings in shares of Molina Healthcare by 2.2% during the 1st quarter. Clear Creek Financial Management LLC now owns 1,462 shares of the company’s stock worth $601,000 after buying an additional 32 shares during the period. Custom Index Systems LLC grew its stake in Molina Healthcare by 5.0% in the 2nd quarter. Custom Index Systems LLC now owns 690 shares of the company’s stock valued at $205,000 after buying an additional 33 shares during the last quarter. GAMMA Investing LLC lifted its position in Molina Healthcare by 11.5% during the 1st quarter. GAMMA Investing LLC now owns 330 shares of the company’s stock worth $136,000 after acquiring an additional 34 shares during the last quarter. Finally, AlphaMark Advisors LLC boosted its holdings in Molina Healthcare by 1.1% during the second quarter. AlphaMark Advisors LLC now owns 3,543 shares of the company’s stock valued at $1,053,000 after acquiring an additional 40 shares during the period. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the transaction, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the sale, the director now directly owns 18,025 shares in the company, valued at $6,114,260.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Maurice Hebert sold 393 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the completion of the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.

Molina Healthcare Price Performance

Molina Healthcare stock opened at $344.56 on Tuesday. Molina Healthcare, Inc. has a one year low of $282.96 and a one year high of $423.92. The stock’s fifty day moving average price is $340.66 and its two-hundred day moving average price is $340.88. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57. The firm has a market cap of $20.19 billion, a PE ratio of 18.70, a price-to-earnings-growth ratio of 1.21 and a beta of 0.57.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The firm had revenue of $9.88 billion during the quarter, compared to analysts’ expectations of $9.75 billion. During the same period in the prior year, the company posted $5.65 EPS. The company’s revenue was up 18.7% on a year-over-year basis. As a group, research analysts expect that Molina Healthcare, Inc. will post 23.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. StockNews.com cut Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, September 18th. Truist Financial dropped their target price on shares of Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a research report on Monday, July 15th. Cantor Fitzgerald restated an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a research report on Tuesday, September 10th. TD Cowen decreased their target price on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a research report on Wednesday, July 24th. Finally, Stephens reaffirmed an “equal weight” rating and issued a $320.00 price target on shares of Molina Healthcare in a report on Thursday, July 25th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $378.00.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.